查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044328

生物活性胜肽食品市場預測至2034年－按產品類型、胜肽成分、功能、加工技術、應用、最終用戶和地區分類的全球分析

Bioactive Peptide-Enriched Foods Market Forecasts to 2034 - Global Analysis By Product Type, Peptide Source, Functional Benefit, Processing Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物活性胜肽強化食品市場規模將達到 64 億美元，並在預測期內以 18.4% 的複合年成長率成長，到 2034 年將達到 248 億美元。

生物活性胜肽強化食品是指含有特定短鏈胺基酸序列的食品，這些序列源自於食品蛋白質（如酪蛋白、乳清蛋白、大豆蛋白、膠原蛋白、海洋蛋白和豆類蛋白）的水解，可提供經臨床驗證的功能性健康益處，超越傳統蛋白質營養。這些生物活性胜肽組成具有多種生物活性，例如透過抑制血管緊張素轉換酶 (ACE) 發揮降血壓作用、調節鴉片受體以增強飽足感和緩解疼痛、抗菌、清除抗氧化自由基、調節抗發炎細胞激素以及免疫調節功能。它們被添加到機能飲料、高蛋白棒和乳製品、膳食補充劑、烘焙食品和速食食品中，用於維護心血管健康、控制血壓、促進運動後恢復和增強免疫力。

功能性蛋白質營養品類的優質化

消費者對蛋白質的認知正在轉變，他們不再僅僅將蛋白質視為增強飽腹感和促進肌肉生長的主要營養素，而是開始將特定的生物活性肽序列視為精準的功能性營養工具，認為其能夠帶來超越傳統蛋白質的顯著生理益處。這種轉變正在推動整個機能性食品和飲料品類的優質化。針對特定胜肽成分的臨床證據，例如用於降低血壓的乳三肽IPP和VPP、用於維護關節健康的膠原蛋白肽以及用於改善認知功能的乳清來源BETA-乳糖苷酶，都支持了其成分層面的健康益處，這些益處足以支撐其在心血管健康、運動營養和認知健康等機能性食品領域高於普通蛋白質強化食品的溢價。

生物活性胜肽的穩定性及其在食品基質加工中所面臨的挑戰

在食品生產過程中，如何維持生物活性胜肽在熱處理、pH波動、消化過程中的酶分解以及與食品基質成分的化學相互作用等因素下的生物活性，是開發生物活性肽強化食品的一項重大技術挑戰。為符合食品安全標準而進行的高溫加工可能會部分破壞某些對生物活性至關重要的胜肽結構，因此需要採用昂貴的包封技術或無菌低溫加工，這顯著增加了生產的複雜性。此外，由於生物活性胜肽在被吸收前會在胃腸道內被蛋白水解酶分解，因此評估其口服生物有效性和劑量反應特性是臨床證據開發項目中一項成本高昂但至關重要的環節。

心血管健康機能性食品處方計劃

醫生和循環系統推薦機能性食品機能性食品能夠提供臨床上有效的降壓肽成分，且劑量達到治療水平，並可作為藥物治療心血管疾病的膳食補充，從而大規模高血壓患者。這些患者已表現出願意投資於經醫療專業人員指導證實有效的、以食物為基礎的心血管風險降低策略的意願。

新食品和健康標籤的監管障礙

對於新發現的生物活性胜肽組分，歐盟1924/2006號法規或同等框架下對食品健康標籤授權提出了嚴格的新食品許可要求，並要求符合嚴格的臨床證據標準，這些都對富含生物活性胜肽的食品的商業化構成了重大的監管投資障礙。歐洲食品安全局（EFSA）歷來對胜肽和蛋白質水解物成分的食品健康標籤核准採取嚴格的限制性方法，始終要求進行多項隨機對照試驗，以證明其結果具有統計意義。因此，生物活性胜肽食品需要進行大量的臨床開發項目，從而延長了上市時間並增加了整體開發成本。

新冠疫情的感染疾病：

疫情期間，消費者對具有免疫支持和心血管健康益處的機能性食品的投資顯著增加，為生物活性胜肽食品的普及創造了有利的市場環境。然而，影響乳清蛋白和海洋蛋白水解物等原料供應的供應鏈中斷曾一度限制了其生產。疫情後，消費者對預防性健康營養和蛋白質品質最佳化的濃厚興趣，使得心血管、免疫和運動營養類生物活性胜肽強化食品的需求持續高漲。

在預測期內，烘焙產品細分市場預計將佔據最大的市場佔有率。

在預測期內，烘焙產品預計將佔據最大的市場佔有率。這是因為全球烘焙類別的龐大銷售量使得生物活性胜肽能夠以麵包、穀物和零食等形式，透過大規模的分銷管道接觸各類消費者。添加了抗高血壓胜肽組分和膠原蛋白肽的麵包和穀物產品，旨在促進心血管和皮膚健康，其優勢在於消費者日常生活中經常食用這些產品，並且它們能夠確保消費者透過現有的飲食習慣攝取具有臨床意義的累積肽含量。

在預測期內，乳源胜肽細分市場預計將呈現最高的複合年成長率。

在預測期內，乳源胜肽領域預計將呈現最高的成長率，這得益於其在生物活性胜肽類別中最廣泛的臨床證據支持。多項隨機對照試驗已為健康聲稱檢驗了可靠的證據，例如乳三肽（異戊酸磷酸酯和異戊酸磷酸酯）的降血壓作用以及酪蛋白磷酸肽促進鈣吸收的作用。透過最佳化酵素水解工藝，乳源生物活性胜肽的商業化生產規模不斷擴大，從而提高了供應效率；而成熟的乳製品配方體係也促進了這些成分在功能性乳製品和飲料產品類型中的整合。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的機能性食品零售基礎設施、消費者對蛋白質營養的深入了解，以及對臨床營養研究的大力投入，這些投入支持了生物活性胜肽食品配料的開發。美國運動營養與心血管健康食品市場是全球含生物活性胜肽產品最大的細分市場。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素：高血壓的高發生率為降血壓機能性食品創造了巨大的潛在市場；日本成熟的傳統胜肽類食品文化，包括生物活性胜肽發酵飲料；以及中國、韓國和印度等國機能性食品市場基礎設施​​的快速擴張。此外，日本支持性的法規結構允許將某些生物活性胜肽標註為「特定機能性食品食品」（FOSHU），這正在推動該地區的產品研發投資。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球含生物活性胜肽食品市場：依產品類型分類

  • 機能飲料
  • 蛋白質棒
  • 乳製品
  • 營養補充品
  • 烘焙產品
  • 即食食品

第6章：全球含生物活性胜肽食品市場：依胜肽來源分類

  • 乳源性胜肽
  • 植物來源肽
  • 海洋來源胜肽
  • 動物源性胜肽
  • 合成胜肽

第7章 全球含生物活性胜肽食品市場：功能性

  • 降低血壓的效果
  • 提高免疫力
  • 消炎（藥）
  • 肌肉生長支持
  • 體重管理

第8章 全球含生物活性胜肽食品市場：依加工技術分類

  • 酵素水解
  • 發酵
  • 薄膜過濾
  • 噴霧乾燥
  • 微膠囊化

第9章 全球含生物活性胜肽食品市場：依應用分類

  • 運動營養
  • 臨床營養
  • 機能性食品
  • 營養保健品
  • 老年人營養

第10章 全球含生物活性胜肽食品市場：依最終用戶分類

  • 食品製造商
  • 營養保健品公司
  • 醫療服務提供方
  • 消費者

第11章 全球含生物活性胜肽食品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Glanbia plc
  • Kerry Group plc
  • Ingredion Incorporated
  • Archer Daniels Midland Company
  • Cargill Incorporated
  • Fonterra Co-operative Group
  • Royal FrieslandCampina
  • DSM-Firmenich
  • Tate & Lyle plc
  • BASF SE
  • Mead Johnson Nutrition
  • Ajinomoto Co., Inc.
Product Code: SMRC36117

According to Stratistics MRC, the Global Bioactive Peptide-Enriched Foods Market is accounted for $6.4 billion in 2026 and is expected to reach $24.8 billion by 2034 growing at a CAGR of 18.4% during the forecast period. Bioactive peptide-enriched foods refer to food products in which specific short-chain amino acid sequences derived from the hydrolysis of food proteins including milk casein, whey, soy, collagen, marine proteins, and legume proteins are incorporated to deliver clinically documented functional health benefits beyond conventional protein nutrition. These bioactive peptide fractions exhibit biological activities including ACE-inhibitory antihypertensive effects, opioid receptor modulation for satiety and pain modulation, antimicrobial activity, antioxidant radical scavenging, anti-inflammatory cytokine modulation, and immunomodulatory functions. They are incorporated into functional beverages, protein enriched bars and dairy products, dietary supplements, bakery formulations, and ready-to-eat meals targeting cardiovascular health, blood pressure management, sports recovery, and immune support.

Market Dynamics:

Driver:

Functional protein nutrition category premiumization

Consumer evolution from viewing protein primarily as a macronutrient for satiety and muscle building toward appreciating specific bioactive peptide sequences as precision functional nutrition tools delivering measurable physiological benefits beyond conventional protein is driving premiumization across functional food and beverage categories. Clinical evidence for specific peptide fractions including Lactotripeptides IPP and VPP in blood pressure reduction, collagen peptides in joint health support, and whey-derived beta-lactolin in cognitive function improvement provides compelling ingredient-level health claim positioning that commands premium pricing above generic protein-fortified food products in cardiovascular health, sports nutrition, and cognitive wellness functional food segments.

Restraint:

Bioactive peptide stability and food matrix processing challenges

Maintaining bioactive peptide biological activity through food manufacturing thermal processing, pH variation, enzymatic degradation during digestion, and chemical interactions with food matrix components represents significant technical challenges for bioactive peptide-enriched food product development. High-temperature processing required for food safety compliance can partially denature specific peptide structures critical for their biological activity, requiring expensive encapsulation protection or aseptic cold processing that substantially increases manufacturing complexity. Gastrointestinal proteolysis further degrades bioactive peptides before absorption, making oral bioavailability and dose-response characterization essential but costly components of clinical evidence development programs.

Opportunity:

Cardiovascular health functional food prescription programs

Physician and cardiologist recommendation of bioactive peptide-enriched functional foods as adjunctive dietary interventions for blood pressure management, cholesterol modulation, and cardiovascular risk factor reduction in pre-hypertensive and mildly hypertensive patient populations represents a high-value healthcare-adjacent distribution channel opportunity. Functional foods delivering clinically validated antihypertensive peptide fractions at therapeutic dose levels, positioned as dietary complement to pharmaceutical cardiovascular management, can access the large hypertensive population segment with documented willingness to invest in food-based cardiovascular risk reduction strategies validated by healthcare professional guidance.

Threat:

Novel food and health claim regulatory hurdles

Stringent novel food authorization requirements for newly characterized bioactive peptide fractions and the demanding clinical evidence standards required for food product health claim authorization under EU Regulation 1924/2006 and equivalent frameworks create substantial regulatory investment barriers for bioactive peptide-enriched food commercialization. EFSA's historically restrictive approach to approving food product health claims for peptide and protein hydrolysate ingredients, requiring multiple randomized controlled trials with consistent statistically significant outcomes, creates extensive clinical development programs that increase time-to-market and total development costs for bioactive peptide food product launches.

Covid-19 Impact:

The pandemic substantially elevated consumer investment in functional foods delivering immune support and cardiovascular health benefits, creating favorable market conditions for bioactive peptide food product adoption. Supply chain disruptions affecting whey and marine protein hydrolysate ingredient availability temporarily constrained production. Post-pandemic, entrenched consumer focus on preventive health nutrition and protein quality optimization maintains elevated demand for bioactive peptide-enriched food products across cardiovascular, immune, and sports nutrition categories.

The bakery products segment is expected to be the largest during the forecast period

The bakery products segment is expected to account for the largest market share during the forecast period, due to the enormous global bakery category volume providing a large-scale vehicle for bioactive peptide incorporation across bread, cereal, and snack formats that reach broad consumer demographics through mass retail channels. Bread and cereal products fortified with antihypertensive peptide fractions and collagen peptide additions addressing cardiovascular health and skin wellness benefit positioning benefit from daily consumption frequency that supports clinically meaningful cumulative peptide intake delivery through established consumer dietary patterns.

The milk-derived peptides segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the milk-derived peptides segment is predicted to witness the highest growth rate, driven by the most extensive clinical evidence base among bioactive peptide categories, with multiple randomized controlled trials validating Lactotripeptides IPP and VPP antihypertensive efficacy and casein phosphopeptide calcium absorption enhancement enabling credible health claim substantiation. Commercial production scale-up of dairy-derived bioactive peptides through enzymatic hydrolysis optimization is improving supply economics, and established dairy food formulation infrastructure facilitates ingredient integration across functional dairy and beverage product categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced functional food retail infrastructure, high consumer protein nutrition sophistication, and strong clinical nutrition research investment supporting bioactive peptide food ingredient development. The United States sports nutrition and cardiovascular wellness food markets represent the highest-value bioactive peptide enrichment application concentrations globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to high hypertension prevalence creating large addressable markets for antihypertensive functional food products, established traditional peptide food cultures in Japan including bioactive peptide fermented beverages, and rapidly growing functional food market infrastructure across China, South Korea, and India. Japanese regulatory frameworks providing supportive FOSHU functional food claim pathways for specific bioactive peptides are driving regional product development investment.

Key players in the market

Some of the key players in Bioactive Peptide-Enriched Foods Market include Nestle S.A., Danone S.A., Abbott Laboratories, Amway Corporation, Herbalife Nutrition Ltd., Glanbia plc, Kerry Group plc, Ingredion Incorporated, Archer Daniels Midland Company, Cargill Incorporated, Fonterra Co-operative Group, Royal FrieslandCampina, DSM-Firmenich, Tate & Lyle plc, BASF SE, Mead Johnson Nutrition, and Ajinomoto Co., Inc..

Key Developments:

In April 2026, Ajinomoto Co., Inc. launched a bioactive peptide functional beverage with clinically validated Lactotripeptide IPP and VPP content demonstrating statistically significant systolic blood pressure reduction in a multi-center randomized controlled trial.

In February 2026, Kerry Group plc introduced a marine collagen bioactive peptide ingredient platform for food fortification demonstrating superior joint health biomarker improvement versus conventional collagen hydrolysate in comparative clinical studies.

In January 2026, DSM-Firmenich released a novel whey-derived bioactive peptide fraction demonstrating cognitive performance enhancement and attention improvement validated in a double-blind crossover trial in healthy adult volunteers.

Product Types Covered:

  • Functional Beverages
  • Protein Bars
  • Dairy Products
  • Dietary Supplements
  • Bakery Products
  • Ready-to-Eat Meals

Peptide Sources Covered:

  • Milk-Derived Peptides
  • Plant-Based Peptides
  • Marine Peptides
  • Animal-Based Peptides
  • Synthetic Peptides

Functional Benefits Covered:

  • Anti-Hypertensive
  • Immunity Boosting
  • Anti-Inflammatory
  • Muscle Growth Support
  • Weight Management

Processing Technologies Covered:

  • Enzymatic Hydrolysis
  • Fermentation
  • Membrane Filtration
  • Spray Drying
  • Microencapsulation

Applications Covered:

  • Sports Nutrition
  • Clinical Nutrition
  • Functional Foods
  • Nutraceuticals
  • Elderly Nutrition

End Users Covered:

  • Food Manufacturers
  • Nutraceutical Companies
  • Healthcare Providers
  • Consumers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Bioactive Peptide-Enriched Foods Market, By Product Type

  • 5.1 Functional Beverages
  • 5.2 Protein Bars
  • 5.3 Dairy Products
  • 5.4 Dietary Supplements
  • 5.5 Bakery Products
  • 5.6 Ready-to-Eat Meals

6 Global Bioactive Peptide-Enriched Foods Market, By Peptide Source

  • 6.1 Milk-Derived Peptides
  • 6.2 Plant-Based Peptides
  • 6.3 Marine Peptides
  • 6.4 Animal-Based Peptides
  • 6.5 Synthetic Peptides

7 Global Bioactive Peptide-Enriched Foods Market, By Functional Benefit

  • 7.1 Anti-Hypertensive
  • 7.2 Immunity Boosting
  • 7.3 Anti-Inflammatory
  • 7.4 Muscle Growth Support
  • 7.5 Weight Management

8 Global Bioactive Peptide-Enriched Foods Market, By Processing Technology

  • 8.1 Enzymatic Hydrolysis
  • 8.2 Fermentation
  • 8.3 Membrane Filtration
  • 8.4 Spray Drying
  • 8.5 Microencapsulation

9 Global Bioactive Peptide-Enriched Foods Market, By Application

  • 9.1 Sports Nutrition
  • 9.2 Clinical Nutrition
  • 9.3 Functional Foods
  • 9.4 Nutraceuticals
  • 9.5 Elderly Nutrition

10 Global Bioactive Peptide-Enriched Foods Market, By End User

  • 10.1 Food Manufacturers
  • 10.2 Nutraceutical Companies
  • 10.3 Healthcare Providers
  • 10.4 Consumers

11 Global Bioactive Peptide-Enriched Foods Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Nestle S.A.
  • 14.2 Danone S.A.
  • 14.3 Abbott Laboratories
  • 14.4 Amway Corporation
  • 14.5 Herbalife Nutrition Ltd.
  • 14.6 Glanbia plc
  • 14.7 Kerry Group plc
  • 14.8 Ingredion Incorporated
  • 14.9 Archer Daniels Midland Company
  • 14.10 Cargill Incorporated
  • 14.11 Fonterra Co-operative Group
  • 14.12 Royal FrieslandCampina
  • 14.13 DSM-Firmenich
  • 14.14 Tate & Lyle plc
  • 14.15 BASF SE
  • 14.16 Mead Johnson Nutrition
  • 14.17 Ajinomoto Co., Inc.

List of Tables

  • Table 1 Global Bioactive Peptide-Enriched Foods Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Bioactive Peptide-Enriched Foods Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Bioactive Peptide-Enriched Foods Market Outlook, By Functional Beverages (2023-2034) ($MN)
  • Table 4 Global Bioactive Peptide-Enriched Foods Market Outlook, By Protein Bars (2023-2034) ($MN)
  • Table 5 Global Bioactive Peptide-Enriched Foods Market Outlook, By Dairy Products (2023-2034) ($MN)
  • Table 6 Global Bioactive Peptide-Enriched Foods Market Outlook, By Dietary Supplements (2023-2034) ($MN)
  • Table 7 Global Bioactive Peptide-Enriched Foods Market Outlook, By Bakery Products (2023-2034) ($MN)
  • Table 8 Global Bioactive Peptide-Enriched Foods Market Outlook, By Ready-to-Eat Meals (2023-2034) ($MN)
  • Table 9 Global Bioactive Peptide-Enriched Foods Market Outlook, By Peptide Source (2023-2034) ($MN)
  • Table 10 Global Bioactive Peptide-Enriched Foods Market Outlook, By Milk-Derived Peptides (2023-2034) ($MN)
  • Table 11 Global Bioactive Peptide-Enriched Foods Market Outlook, By Plant-Based Peptides (2023-2034) ($MN)
  • Table 12 Global Bioactive Peptide-Enriched Foods Market Outlook, By Marine Peptides (2023-2034) ($MN)
  • Table 13 Global Bioactive Peptide-Enriched Foods Market Outlook, By Animal-Based Peptides (2023-2034) ($MN)
  • Table 14 Global Bioactive Peptide-Enriched Foods Market Outlook, By Synthetic Peptides (2023-2034) ($MN)
  • Table 15 Global Bioactive Peptide-Enriched Foods Market Outlook, By Functional Benefit (2023-2034) ($MN)
  • Table 16 Global Bioactive Peptide-Enriched Foods Market Outlook, By Anti-Hypertensive (2023-2034) ($MN)
  • Table 17 Global Bioactive Peptide-Enriched Foods Market Outlook, By Immunity Boosting (2023-2034) ($MN)
  • Table 18 Global Bioactive Peptide-Enriched Foods Market Outlook, By Anti-Inflammatory (2023-2034) ($MN)
  • Table 19 Global Bioactive Peptide-Enriched Foods Market Outlook, By Muscle Growth Support (2023-2034) ($MN)
  • Table 20 Global Bioactive Peptide-Enriched Foods Market Outlook, By Weight Management (2023-2034) ($MN)
  • Table 21 Global Bioactive Peptide-Enriched Foods Market Outlook, By Processing Technology (2023-2034) ($MN)
  • Table 22 Global Bioactive Peptide-Enriched Foods Market Outlook, By Enzymatic Hydrolysis (2023-2034) ($MN)
  • Table 23 Global Bioactive Peptide-Enriched Foods Market Outlook, By Fermentation (2023-2034) ($MN)
  • Table 24 Global Bioactive Peptide-Enriched Foods Market Outlook, By Membrane Filtration (2023-2034) ($MN)
  • Table 25 Global Bioactive Peptide-Enriched Foods Market Outlook, By Spray Drying (2023-2034) ($MN)
  • Table 26 Global Bioactive Peptide-Enriched Foods Market Outlook, By Microencapsulation (2023-2034) ($MN)
  • Table 27 Global Bioactive Peptide-Enriched Foods Market Outlook, By Application (2023-2034) ($MN)
  • Table 28 Global Bioactive Peptide-Enriched Foods Market Outlook, By Sports Nutrition (2023-2034) ($MN)
  • Table 29 Global Bioactive Peptide-Enriched Foods Market Outlook, By Clinical Nutrition (2023-2034) ($MN)
  • Table 30 Global Bioactive Peptide-Enriched Foods Market Outlook, By Functional Foods (2023-2034) ($MN)
  • Table 31 Global Bioactive Peptide-Enriched Foods Market Outlook, By Nutraceuticals (2023-2034) ($MN)
  • Table 32 Global Bioactive Peptide-Enriched Foods Market Outlook, By Elderly Nutrition (2023-2034) ($MN)
  • Table 33 Global Bioactive Peptide-Enriched Foods Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 Global Bioactive Peptide-Enriched Foods Market Outlook, By Food Manufacturers (2023-2034) ($MN)
  • Table 35 Global Bioactive Peptide-Enriched Foods Market Outlook, By Nutraceutical Companies (2023-2034) ($MN)
  • Table 36 Global Bioactive Peptide-Enriched Foods Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 37 Global Bioactive Peptide-Enriched Foods Market Outlook, By Consumers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.